GGrantIndex
Sort

50,496 grants matching lung cancer

Identification and targeting of the signaling pathways underlying lung cancer.

$432,000
Joseph Kissil · Scripps Florida · R01 · FY2015 · CA

Identification and targeting of the signaling pathways underlying lung cancer.

$432,000
Joseph Kissil · Scripps Florida · R01 · FY2017 · CA

Identification and targeting of the signaling pathways underlying lung cancer.

$432,000
Joseph Kissil · Scripps Florida · R01 · FY2018 · CA

Antecedants Sequelae of Childhood Onset Disease

$432,000
Julio Perez Fontan · Ut Southwestern Medical Center · K12 · FY2014 · HD

Targeting LSD1 to prevent therapy-induced transdifferentiation in BRAF mutant colorectal cancer

$431,920
Heather M O'Hagan · Indiana University Indianapolis · R01 · FY2024 · CA

RET Regulation and Targeting in Neuroendocrine Prostate Cancer

$431,919
Justin Michael Drake · University Of Minnesota · R01 · FY2023 · CA

Systematic characterization of cancer variants using single-cell functional genomics

$431,914
Thomas Maxwell Norman · Sloan-Kettering Inst Can Research · R33 · FY2023 · CA

SCH: INT: Harnessing the Power of Technology: MOMBA for Postpartum Smoking

$431,898
Megan Veenema Smith · Yale University · R01 · FY2017 · CA

Antigen-targeted activation of Topo1 inhibitors via click chemistry

$431,859
Jose M Mejia Oneto · Shasqi, Inc. · R44 · FY2025 · CA

Tumor-specific autoantibodies for SCLC early detection

$431,826
A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

Mechanisms of cannabinoid-resistance among oral spirochetes

$431,750
David A Scott · University Of Louisville · R21 · FY2025 · DE

Biological mechanisms underlying the relationships between environmental exposures and risk of respiratory and cardiovascular diseases

$431,731
Jason Wong · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Role of BMDCs in Solid Tumor Growth and Relapse

$431,698
Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2007 · CA

Role of Etv4 and Etv5 in the self-renewal and differentiation of nephron progenitors

$431,692
Cristina Cebrian Ligero · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · DK

Mechanisms linking hemostatic factors and malignancy

$431,691
Children'S Hospital Med Ctr (Cincinnati) · R01 · FY2004 · HL

PDT of Head and Neck Cancer

$431,681
Nestor Rafael Rigual · Roswell Park Cancer Institute Corp · P01 · FY2010 · CA

Role of SOX9 mammary stem cell factor in metastasis

$431,673
Wenjun Guo · Albert Einstein College Of Medicine · P01 · FY2022 · CA

Therapeutic Targeting of Breast Cancer Tumor Initiating Cells

$431,667
Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA

A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children

$431,631
Pan Zheng · University Of Maryland Baltimore · R01 · FY2018 · CA

In Vivo Studies of the Epileptic Hippocampus

$431,612
Jerome None Engel · University Of California Los Angeles · R01 · FY2014 · NS

Normalizing Gene Expression Data from Formalin-Fixed Paraffin-Embedded Samples

$431,586
Xinlei Wang · Southern Methodist University · R15 · FY2019 · GM

A transformative drug discovery platform for allosteric kinase inhibitors

$431,555
Nicholas Mark Levinson · University Of Minnesota · R01 · FY2024 · CA

Role of NADPH Oxidase in Regulating Inflammation

$431,525
Brahm H. Segal · Roswell Park Cancer Institute Corp · R01 · FY2012 · AI

Nrf2 and Radiation-induced pulmonary fibrosis.

$431,511
Michael L. Freeman · Vanderbilt University · R01 · FY2015 · HL

Macro-vasculature: A Novel Image Biomarker of Lung Cance

$431,503
Jiantao Pu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA